Endogenous inhibitors of angiogenesis: a historical review.
about
αV integrins in angiogenesis and cancerBroad targeting of angiogenesis for cancer prevention and therapyMolecular therapy of colorectal cancer: progress and future directionsPersistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinomaVicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activitiesMulti-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapyThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyMatrix metalloproteinases: regulators of the tumor microenvironmentCHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis.Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts.Circulating angiogenic factors in patients with thromboangiitis obliterans.Anti-angiogenic treatment strategies for the therapy of endometriosis.Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factorComputational systems biology approaches to anti-angiogenic cancer therapeutics.Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.Angiogenesis and melanoma - from basic science to clinical trials.A reduced graphene oxide-based fluorescence resonance energy transfer sensor for highly sensitive detection of matrix metalloproteinase 2.Radio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs.Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis.The VEGF pathway in cancer and disease: responses, resistance, and the path forward.A new chromogranin A-dependent angiogenic switch activated by thrombin.Why are epididymal tumours so rare?Inhibitory effect of endostatin gene therapy combined with phosphorus-32 colloid on tumour growth in Wistar rats.Controlling escape from angiogenesis inhibitors.Anti-Parstatin Promotes Angiogenesis and Ameliorates Left Ventricular Dysfunction during Pressure Overload.Tumor vasculature as target for therapeutic intervention.Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets.Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanisms.Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer.
P2860
Q26851768-A23EF8D4-DE1F-4492-932F-C685A53A2D62Q27002903-297F7A51-291A-4714-BAF5-828C15CB4B1BQ27005764-F247F6F0-FC61-407E-A6D1-34322F5BAE96Q27012236-7A361495-087E-45DD-AFB2-BDF72C7EAD52Q28751757-0B8D64DB-55DE-4CC3-AF37-9CF12A809521Q28818449-887A63B0-882C-455F-B8DC-807AAF75A27FQ29040166-A3072F70-F818-4385-84C1-991B99FFF206Q29619858-B20A8ACA-9B42-4746-BC70-A4ED26565B48Q33648419-0F474BE3-1B79-4FF0-9BED-409F369AC06BQ33692555-40DE987D-1608-4C58-8274-C6747D62F74BQ33824563-24B82E57-4A14-4A2B-8D1B-0AB0018DA878Q33886478-600641AB-63F0-4683-9773-AD933738A866Q34233678-A8AE28AA-8792-4315-95C8-365A33AAD6ACQ34283036-8ED6B021-F246-4BCD-85EA-0DE69E74BF93Q34391833-4C03C797-0DAB-4B5B-988D-BA1142420573Q34392057-E7279B58-48EF-4DB0-8F4B-3DD79547B8B2Q34733388-F7A60D48-FEE4-421A-AAD7-1912A7064F0DQ35091440-8F85E255-A888-422C-834D-71332E31AFFCQ35108084-E7C8D545-A3AF-4D36-B5AB-6A5C476F41D0Q35175046-E5104866-EB6E-4A9A-82D2-2A2139EA31CAQ35380959-76F6F1F5-5332-4B11-8808-7925517A6B9EQ36008261-9BEA3944-6C89-4F89-8C5D-FBCD244BF995Q36086207-C714C678-3355-4A82-861B-048A3B669056Q36279079-C3ED8E16-73E6-46BB-83D5-53D0FF2B1024Q36385822-459675DE-74F8-4CD9-B602-180195572259Q36526512-14340CB4-11DE-4D96-BB78-80DAABAD06C7Q36529507-B4B87292-9B76-4B58-BD1B-30201CC45E7AQ37037784-E55A72EA-72CA-471D-A25F-B1111546455AQ37626801-A45A3525-BB8F-4E10-B146-C65BF77685C4Q37672654-A96552CA-472A-42B1-8BAD-F1816DD012D9Q37685882-6A27D2A0-C65B-4A11-BDB8-F939A961F66BQ37800110-3AC6DEE1-DFB4-46F7-BE68-79D25F397AA3Q37915101-559E16A2-9FEE-46CB-ABA7-09B5A60FD801Q37998372-A6C6F7AA-AB52-4E98-B7F1-1669B511D325Q38086269-8D557D55-0B49-459A-9F98-9179F6CED4B5Q38130312-C0CAB8AB-8EFE-4F7A-B8CD-FC2594687EE2Q38186064-68FC122F-AB0D-4E60-87D9-4C4262BDD629Q38188373-A7A4B627-26E9-44EB-BA82-3ACEB9F54E89Q38525073-93EBAF72-D1B5-4722-AFA7-867F26C45168Q38533166-0C97A92E-F962-4DF0-84B3-B17A346271A0
P2860
Endogenous inhibitors of angiogenesis: a historical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endogenous inhibitors of angiogenesis: a historical review.
@en
Endogenous inhibitors of angiogenesis: a historical review.
@nl
type
label
Endogenous inhibitors of angiogenesis: a historical review.
@en
Endogenous inhibitors of angiogenesis: a historical review.
@nl
prefLabel
Endogenous inhibitors of angiogenesis: a historical review.
@en
Endogenous inhibitors of angiogenesis: a historical review.
@nl
P1433
P1476
Endogenous inhibitors of angiogenesis: a historical review.
@en
P304
P356
10.1016/J.LEUKRES.2008.11.019
P577
2008-12-31T00:00:00Z